Camson Bio Technologies Limited reported unaudited standalone earnings results for the first quarter ended June 30, 2018. For the quarter, the company reported revenue from operations of INR 12.898 million compared to INR 112.659 million a year ago. Loss before tax and exception/extraordinary item was INR 40.315 million against profit of INR 18.207 million a year ago. Loss before tax was INR 40.315 million compared to profit before tax of INR 18.207 million a year ago. Loss for the period was INR 42.620 million compared to profit for the period of INR 18.207 million a year ago. Basic and diluted loss per share was INR 1.42 compared to basic and diluted earnings per share of INR 0.61 a year ago.